These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 24351084)

  • 1. Casting doubt on the traditional approach of cancer biomarker discovery through proteomics.
    Kondo T
    Expert Rev Proteomics; 2014 Feb; 11(1):9-12. PubMed ID: 24351084
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteomics in translational cancer research: biomarker discovery for clinical applications.
    Cho WC
    Expert Rev Proteomics; 2014 Apr; 11(2):131-3. PubMed ID: 24646121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genomics and proteomics approaches for biomarker discovery in sporadic colorectal cancer with metastasis.
    González-González M; Garcia JG; Montero JA; Fernandez LM; Bengoechea O; Muñez OB; Orfao A; Sayagues JM; Fuentes M
    Cancer Genomics Proteomics; 2013; 10(1):19-25. PubMed ID: 23382583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cancer proteomics.
    Tan HT; Lee YH; Chung MC
    Mass Spectrom Rev; 2012; 31(5):583-605. PubMed ID: 22422534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteomic approaches to the discovery of cancer biomarkers for early detection and personalized medicine.
    Honda K; Ono M; Shitashige M; Masuda M; Kamita M; Miura N; Yamada T
    Jpn J Clin Oncol; 2013 Feb; 43(2):103-9. PubMed ID: 23248327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mass spectrometry-based membrane proteomics in cancer biomarker discovery.
    Mermelekas G; Zoidakis J
    Expert Rev Mol Diagn; 2014 Jun; 14(5):549-63. PubMed ID: 24820261
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Profiling proteoforms: promising follow-up of proteomics for biomarker discovery.
    Lisitsa A; Moshkovskii S; Chernobrovkin A; Ponomarenko E; Archakov A
    Expert Rev Proteomics; 2014 Feb; 11(1):121-9. PubMed ID: 24437377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Strategies for plasma proteomic profiling of cancers.
    Omenn GS
    Proteomics; 2006 Oct; 6(20):5662-73. PubMed ID: 16991194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Towards a better knowledge of breast cancer physiopathology: the proteomics approach].
    Hamrita B; Ben Nasr H; Hammann P; Kuhn L; Ben Anes A; Dimassi S; Chaieb A; Khairi H; Chahed K
    Ann Biol Clin (Paris); 2012 Oct; 70(5):553-65. PubMed ID: 23047902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Proteomics for biomarker development toward personalized medicine].
    Kondo T
    Rinsho Byori; 2012 Jul; 60(7):644-9. PubMed ID: 22973724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical proteomics: discovery of cancer biomarkers using mass spectrometry and bioinformatics approaches--a prostate cancer perspective.
    Matharoo-Ball B; Ball G; Rees R
    Vaccine; 2007 Sep; 25 Suppl 2():B110-21. PubMed ID: 17916461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteomics and biomarkers for ovarian cancer diagnosis.
    Zhang B; Barekati Z; Kohler C; Radpour R; Asadollahi R; Holzgreve W; Zhong XY
    Ann Clin Lab Sci; 2010; 40(3):218-25. PubMed ID: 20689132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteomic approaches in lung cancer biomarker development.
    Cho JY; Sung HJ
    Expert Rev Proteomics; 2009 Feb; 6(1):27-42. PubMed ID: 19210125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. iTRAQ-labeling for biomarker discovery.
    Desouza LV; Voisin SN; Siu KW
    Methods Mol Biol; 2013; 1002():105-14. PubMed ID: 23625398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer proteomics: from biomarker discovery to signal pathway profiling.
    Bichsel VE; Liotta LA; Petricoin EF
    Cancer J; 2001; 7(1):69-78. PubMed ID: 11269650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urinary proteomics--a tool for biomarker discovery.
    Pejcic M; Stojnev S; Stefanovic V
    Ren Fail; 2010 Jan; 32(2):259-68. PubMed ID: 20199189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrated pipeline for mass spectrometry-based discovery and confirmation of biomarkers demonstrated in a mouse model of breast cancer.
    Whiteaker JR; Zhang H; Zhao L; Wang P; Kelly-Spratt KS; Ivey RG; Piening BD; Feng LC; Kasarda E; Gurley KE; Eng JK; Chodosh LA; Kemp CJ; McIntosh MW; Paulovich AG
    J Proteome Res; 2007 Oct; 6(10):3962-75. PubMed ID: 17711321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contribution of DNA and tissue microarray technology to the identification and validation of biomarkers and personalised medicine in breast cancer.
    Brennan DJ; Kelly C; Rexhepaj E; Dervan PA; Duffy MJ; Gallagher WM
    Cancer Genomics Proteomics; 2007; 4(3):121-34. PubMed ID: 17878516
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Applications of urinary proteomics in biomarker discovery.
    Shao C; Wang Y; Gao Y
    Sci China Life Sci; 2011 May; 54(5):409-17. PubMed ID: 21455690
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implications of salivary proteomics in drug discovery and development: a focus on cancer drug discovery.
    Hu S; Yen Y; Ann D; Wong DT
    Drug Discov Today; 2007 Nov; 12(21-22):911-6. PubMed ID: 17993408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.